Skip to main content
. Author manuscript; available in PMC: 2014 Feb 1.
Published in final edited form as: Neuropharmacology. 2012 Sep 26;65:39–47. doi: 10.1016/j.neuropharm.2012.09.009

Table 2.

Effects of LAG infusions on performance on variants of the standard 5CSRTT

Short Stimulus Duration Long Stimulus Duration
Measure 0.0 10.0 0 10.0
Premature Responses 58.44 ± 2.98 58.64 ± 2.94 90.21 ± 1.78 90.00 ± 3.01
Magazine Entries 164.3 ± 22.4 152.9 ± 32.0 167.2 ± 22.5 142.9 ± 19.9
Correct Latency (sec) 0.80 ± 0.07 0.86 ± 0.08 1.39 ± 0.13 1.79 ± 0.10*

Note: Drug was infused in a volume of 0.5 μL/side at the dose indicated; infusions occurred 25 min prior to testing. In the short stimulus duration task the aperture light was illuminated for 0.5 sec. In the long stimulus duration task the aperture light was illuminated for 5 sec.

*

P < 0.05 compared 0.0.